Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Norsk Gjenvinning in connection with its acquisition of MIREC Recycling Solutions AB
Mandate

Vinge advises Norsk Gjenvinning in connection with its acquisition of MIREC Recycling Solutions AB

October 06, 2021 EU, Competition and Regulatory Real Estate and Construction M&A Environmental Law Corporate Commercial

Vinge advises the Norsk Gjenvinning Group in connection with its acquisition of MIREC Recycling Solutions AB, a Swedish leading player within recycling and reuse of electrical equipment (EE waste).

The acquisition is in line with the Norsk Gjenvinning Group's strategy to strengthen its presence in the Nordic region, as well as establish a leading position in the market segment for EE waste.

Vinge’s team mainly consisted of Christina Kokko, Hannah Kajlinger and Gustav Persson (M&A), Johan Cederblad and Lina Österberg (Environment), Lisa Hörnqvist (Commercial agreements), Carl Östlund (Employment), Sebastian Örndahl (Competition), Ulf Pyk (Real Estate), and Klara Lundquist (VDR-assistant).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025